Maturitas
Volume 56, Issue 3 , Pages 257-262 , 20 March 2007

Dry eye in post-menopausal women using hormone replacement therapy

  • Uzeyir Erdem

      Affiliations

    • Department of Ophthalmology, Gulhane Military Medical Faculty, 06018 Etlik, Ankara, Turkey
    • Corresponding Author InformationCorresponding author. Tel.: +90 312 3237835; fax: +90 312 3045850.
    • ,
  • Ozlem Ozdegirmenci

      Affiliations

    • T.C.S.B Etlik Women Hospital, Ankara, Turkey
    • ,
  • Emine Sobaci

      Affiliations

    • T.C.S.B Etlik Women Hospital, Ankara, Turkey
    • ,
  • Güngör Sobaci

      Affiliations

    • Department of Ophthalmology, Gulhane Military Medical Faculty, 06018 Etlik, Ankara, Turkey
    • ,
  • Umit Göktolga

      Affiliations

    • Department of Obstetrics & Gynecology, Gulhane Military Medical Faculty, Ankara, Turkey
    • ,
  • Selim Dagli

      Affiliations

    • Department of Ophthalmology, Gulhane Military Medical Faculty, 06018 Etlik, Ankara, Turkey

Received 12 February 2006 ,Revised 22 August 2006 ,Accepted 25 August 2006.

References 

  1. Schaumberg DA, Sullivan DA, Buring JE, Dana MR. Prevalence of dry eye syndrome among US women. Am J Ophthalmol. 2003;136:318–326
  2. Lin PY, Tsai SY, Cheng CY, Liu CH, Chou P, Hsu WM. Prevalence of dry eye among an elderly Chinese population in Taiwan: the Shihpai Eye Study. Ophthalmology. 2003;110:1096–1101
  3. Chia EM, Mitchell P, Rochtchina E, Lee AJ, Maroun R, Wang JJ. Prevalence and associations of dry eye syndrome in an older population: the Blue Mountains Eye Study. Clin Experiment Ophthalmol. 2003;31(3):229–232
  4. McCarty CA, Bansal AK, Livingston PM, Stanislavsk YL, Taylor HR. The epidemiology of dry eye in Melbourne, Australia. Ophthalmology. 1998;105(6):1114–1119
  5. Bron AJ. Diagnosis of dry eye. Surv Ophthalmol. 2001;45(Suppl 2):S221–S226
  6. Mathers WD, Stovall D, Lane JA, Zimmerman MD, Johnson S. Menopause and tear function: the influence of prolactin and sex hormones on human tear production. Cornea. 1998;7(4):353–358
  7. Schaumberg DA, Buring JE, Sullivan DA, Dana MR. Hormone replacement therapy and dry eye syndrome. JAMA. 2001;7:286(17):2114–2119
  8. Evans V, Millar TJ, Eden JA, Willcox MDP. Hormone replacement therapy and tear function. Cornea. 2000;19(6 Suppl 2):S85
  9. Affinito P, Di Spiezio SA, Di Carlo C, et al. Effect of hormone replacement therapy on ocular function in postmenapause. Menopause. 2003;10(5):482–487
  10. Guaschino S, Grimaldi E, Sartore A, et al. Visual function in menopause: the role of hormone replacement therapy. Menopause. 2003;10(1):53–57
  11. Lang Y, Lang N, Ben-Ami M, Garzozi H. The effects of hormone replacement therapy (HRT) on the human eye. Harefuah. 2002;141(3):287–291313, 312
  12. Abelson MB, Ousler GW, Nally LA, Krenzer K. Alternative reference values for tear film break-up time in normal and dry eye populations. Cornea. 2000;19(6 Suppl 2):S72
  13. Smith W, Mitchell P, Wang JI. Gender, oestrogen hormone replacement and age-related macular degeneration: results from the Blue Mountains Eye Study. Aust NZ J Ophthalmol. 1997;25(Suppl):S13–S15
  14. Klein BE, Klein R, Ritter LL. Is there evidence of estrogen effect on age-related lens opacities? The Beaver Dam Eye Study. Arch Ophthalmol. 1994;112:85–91
  15. Van Bijsterveld OP. Diagnostic tests in the sicca syndrome. Arch Ophthalmol. 1969;2:10–14
  16. Smith RE. The tear film complex. Pathogenesis and emerging therapies for dry eye. Cornea. 2005;24(1):1–7
  17. Metka M, Enzeisberger H, Knogier W, Schurz B, Aichmair H. Ophthalmic complaints as a climacteric symptoms. Maturitas. 1991;14(1):3–8
  18. Mathers WD, Strovall D, Lane JA, Zimmerman MB. Menopause and tear function: the influence of prolactin and sex hormones on human tear production. Cornea. 1998;17(4):353–358
  19. Sullivan DA, Belanger A, Cermak JM, et al. Are women with Sjogren's syndrome androgen-deficient?. J Rheumatol. 2003;30(11):2413–2419
  20. Labrie F. Extragonadal synthesis of sex steroids: intracrinology. Ann Endocrinol. 2003;64(2):95–107
  21. Scialfa CT, Tyrrell RA, Garvey PM, Deering LM, Leibowitz HW, Goebel CC. Age differences in Vistech near contrast sensitivity. Am J Optom Physiol Opt. 1988;65(12):951–956
  22. Gurwood AS, Gurwood I, Gubman DT, Brezezicki LJ. Idıosyncratic ocular symptoms associated with the estradiol transdermal estrogen replacement patch system. Optom Vis Sci. 1995;72(1):29–33
  23. McCarty McCarty CA, Ng I, Waldron B, et al. Relation of hormone and menopausal status to outcomes following excimer laser photorefractive keratectomy in women. Melbourne Excimer Laser Group. Aust NZ J Ophthalmol. 1996;24(3):215–222
  24. Akramian J, Wedrich A, Nepp J, Sator M. Estrogen therapy in keratoconjunctivitis sicca with topical estradiol. Adv Exp Med Biol. 1998;438:1005–1009

PII: S0378-5122(06)00311-2

doi: 10.1016/j.maturitas.2006.08.007

Maturitas
Volume 56, Issue 3 , Pages 257-262 , 20 March 2007

Article Tools